Literature DB >> 6310044

Localization of the coding region for a 35000 Dalton polypeptide on the genome of herpes simplex virus type 2.

M Suh, C Chauvin, M Filion, G C Shore, E Frost.   

Abstract

The cloned BglII N fragment of herpes simplex virus type 2 (HSV-2) DNA has been shown to code for a 35K polypeptide. Subfragments made by cleavage with XhoI, BamHI, SstII and XorII were then cloned and used with RNA extracted from HSV-2-infected cells for mRNA selection and in vitro protein synthesis. We found that the major translation product of such hybrid-selected mRNA has a molecular weight of 35 000. By further mapping, DNA coding sequences for this mRNA were located within the region of BglII N, at approximately 0.585 to 0.596 genome map units. DNA sequences complementary to mRNA encoding a 56K polypeptide were located between 0.607 and 0.612 map units.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6310044     DOI: 10.1099/0022-1317-64-9-2079

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  Characterization of mRNAs that map in the BglII N fragment of the herpes simplex virus type 2 genome.

Authors:  F J Jenkins; M K Howett
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

2.  Failure to detect viral genomic sequences of three viruses (herpes simplex, simian virus 40 and adenovirus) in human and rat brain tumors.

Authors:  C Chauvin; M Suh; C Remy; A L Benabid
Journal:  Ital J Neurol Sci       Date:  1990-08

3.  Enhancement of herpes simplex virus type 2 (HSV-2) DNA synthesis in infected cells that constitutively express the BglII-N region of the HSV-2 genome.

Authors:  P G Lee; J Y Chang; M S Yen; Y C Cheng; L M Nutter
Journal:  Virus Genes       Date:  1989-05       Impact factor: 2.332

4.  Retention of herpes simplex virus type II sequences in bglII n-transformed cells after co-transfection with a selectable marker.

Authors:  C Saavedra; A Kessous-Elbaz
Journal:  EMBO J       Date:  1985-12-16       Impact factor: 11.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.